Trial intelligence / Profile preview

PALLIATE-AF: LBBAP and AV Node Ablation in Symptomatic Atrial Fibrillation

NCT06699342Recruiting

Sponsor
Seoul National University Hospital
Start
Jan 2025
Primary completion
Dec 2027
Countries
1
01

Overview

Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: N-terminal pro b-type natriuretic peptide at 6 months. Started Jan 2025; status: recruiting.

02

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT06699342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06699342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call